Snapshot · Russell 3000 · generated 2026-10-17 22:05 UTC

CORT — Corcept Therapeutics Incorporated

EXPENSIVE (MOS Model unreliable) · Quality 73/100

CORT - Corcept Therapeutics Incorporated
Data generated 2026-10-17 22:05 UTC (nightly scan, universe: Russell 3000).
Price: 110.16 USD
Intrinsic value: 27.48 USD
Margin of safety: Model unreliable
Implied growth (reverse DCF): +34.5% (model assumes +7.7%)
Valuation: EXPENSIVE
Value Score: 19
Quality: 73/100
Moat score: 43.8 (erosion: watch)
EXPENSIVE (MOS Model unreliable) - Quality 73/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/CORT
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

110.16

Intrinsic value

27.48

Margin of safety

Model unreliable

Implied growth (reverse DCF)

+34.5%

model assumes +7.7%

Value Score

Quality

Psychology

10.9

Discovery

price/volume attention only

Moat score

43.8

erosion: watch

Value Score: bottom 22% of Russell 3000 · Quality: top 25%

Open the interactive Deep Dive for CORT →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/CORT - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is CORT undervalued?

As of 2026-10-17, CORT trades at 110.16 against a computed intrinsic value of 27.48 (-300.9% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Corcept Therapeutics Incorporated's Value Score?

Corcept Therapeutics Incorporated's Value Score is 19 as of 2026-10-17 - it combines value, quality, crowd psychology and market attention into one number.